News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genmab A/S (GEN.CO) Announces Financial Results for the First Quarter 2012



5/15/2012 9:18:09 AM

COPENHAGEN K, Denmark, May 15, 2012 (GLOBE NEWSWIRE) -- "We have achieved a number of business milestones during the last months including the filing of the New Drug Application (NDA) in Japan for ofatumumab and another milestone in our Lundbeck collaboration. We also continue to focus on resources and in the first quarter of the year we have improved the operating result and lowered operating expenses compared to the same period last year," said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES